{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:17:22Z","timestamp":1767028642830,"version":"3.48.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470430"],"award-info":[{"award-number":["82470430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05358-4","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:12:28Z","timestamp":1767028348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlation between hypertension and restenosis after endovascular therapy: a meta-analysis based on a derived cohort from randomized trials"],"prefix":"10.1186","volume":"25","author":[{"given":"Cheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yarong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"9994","key":"5358_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(15)61220-X","volume":"386","author":"R Piccolo","year":"2015","unstructured":"Piccolo R, Giustino G, Mehran R, Windecker S. Stable coronary artery disease: revascularisation and invasive strategies. Lancet. 2015;386(9994):702\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(15)61220-X.","journal-title":"Lancet"},{"issue":"4","key":"5358_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jacc.2022.05.017","volume":"80","author":"G Giustino","year":"2022","unstructured":"Giustino G, Colombo A, Camaj A, et al. Coronary in-stent restenosis. J Am Coll Cardiol. 2022;80(4):348\u201372. https:\/\/doi.org\/10.1016\/j.jacc.2022.05.017.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"5358_CR3","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","volume":"65","author":"G Giustino","year":"2015","unstructured":"Giustino G, Baber U, Sartori S, et al. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2015;65(13):1298\u2013310. https:\/\/doi.org\/10.1016\/j.jacc.2015.01.039.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"5358_CR4","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1161\/circresaha.121.318261","volume":"128","author":"JA Beckman","year":"2021","unstructured":"Beckman JA, Schneider PA, Conte MS. Advances in revascularization for peripheral artery disease: revascularization in PAD. Circ Res. 2021;128(12):1885\u2013912. https:\/\/doi.org\/10.1161\/circresaha.121.318261.","journal-title":"Circ Res"},{"issue":"4","key":"5358_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1161\/ATVBAHA.119.312449","volume":"39","author":"R Chakraborty","year":"2019","unstructured":"Chakraborty R, Saddouk FZ, Carrao AC, Krause DS, Greif DM, Martin KA. Promoters to study vascular smooth muscle. Arterioscler Thromb Vasc Biol. 2019;39(4):603\u201312. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312449.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"5358_CR6","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1161\/01.cir.92.10.2995","volume":"92","author":"RL Wilensky","year":"1995","unstructured":"Wilensky RL, March KL, Gradus-Pizlo I, Sandusky G, Fineberg N, Hathaway DR. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation. 1995;92(10):2995\u20133005. https:\/\/doi.org\/10.1161\/01.cir.92.10.2995.","journal-title":"Circulation"},{"issue":"7","key":"5358_CR7","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.115.308237","volume":"118","author":"C Gareri","year":"2016","unstructured":"Gareri C, De Rosa S, Indolfi C. MicroRNAs for restenosis and thrombosis after vascular injury. Circ Res. 2016;118(7):1170\u201384. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.308237.","journal-title":"Circ Res"},{"issue":"4","key":"5358_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3109\/03008200903329771","volume":"51","author":"JW Freeman","year":"2010","unstructured":"Freeman JW, Snowhill PB, Nosher JL. A link between stent radial forces and vascular wall remodeling: the discovery of an optimal stent radial force for minimal vessel restenosis. Connect Tissue Res. 2010;51(4):314\u201326. https:\/\/doi.org\/10.3109\/03008200903329771.","journal-title":"Connect Tissue Res"},{"issue":"11","key":"5358_CR9","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1161\/CIRCRESAHA.122.320846","volume":"130","author":"Y Tang","year":"2022","unstructured":"Tang Y, Jia Y, Fan L, et al. MFN2 prevents neointimal hyperplasia in vein grafts via destabilizing PFK1. Circ Res. 2022;130(11):e26\u201343. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.320846.","journal-title":"Circ Res"},{"issue":"5","key":"5358_CR10","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/cvr\/cvw257","volume":"113","author":"K Huang","year":"2017","unstructured":"Huang K, Bao H, Yan ZQ, et al. MicroRNA-33 protects against neointimal hyperplasia induced by arterial mechanical stretch in the grafted vein. Cardiovasc Res. 2017;113(5):488\u201397. https:\/\/doi.org\/10.1093\/cvr\/cvw257.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"5358_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.118.007023","volume":"12","author":"E Shlofmitz","year":"2019","unstructured":"Shlofmitz E, Iantorno M, Waksman R. Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review. Circ Cardiovasc Interv. 2019;12(8):e007023. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.118.007023.","journal-title":"Circ Cardiovasc Interv"},{"key":"5358_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.biopha.2018.03.120","volume":"102","author":"JR Zhang","year":"2018","unstructured":"Zhang JR, Lu QB, Feng WB, et al. Nesfatin-1 promotes VSMC migration and neointimal hyperplasia by upregulating matrix metalloproteinases and downregulating PPAR\u03b3. Biomed Pharmacother. 2018;102:711\u20137. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.120.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"5358_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41374-018-0103-y","volume":"99","author":"SR Datla","year":"2019","unstructured":"Datla SR, Seidel-Rogol LLH. Poldip2 knockdown inhibits vascular smooth muscle proliferation and Neointima formation by regulating the expression of PCNA and p21. Lab Invest. 2019;99(3):387\u201398. https:\/\/doi.org\/10.1038\/s41374-018-0103-y.","journal-title":"Lab Invest"},{"issue":"2","key":"5358_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/CIRCULATIONAHA.116.023381","volume":"137","author":"G Suna","year":"2018","unstructured":"Suna G, Wojakowski W, Lynch M, et al. Extracellular matrix proteomics reveals interplay of Aggrecan and aggrecanases in vascular remodeling of stented coronary arteries. Circulation. 2018;137(2):166\u201383. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023381.","journal-title":"Circulation"},{"issue":"15","key":"5358_CR15","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.120.053361","volume":"144","author":"C Mao","year":"2021","unstructured":"Mao C, Ma Z, Jia Y, et al. Nidogen-2 maintains the contractile phenotype of vascular smooth muscle cells and prevents Neointima formation via bridging Jagged1-Notch3 signaling. Circulation. 2021;144(15):1244\u201361. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.053361.","journal-title":"Circulation"},{"key":"5358_CR16","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.omtn.2021.01.024","volume":"23","author":"X Yang","year":"2021","unstructured":"Yang X, Yang Y, Guo J, et al. Targeting the epigenome in in-stent restenosis: from mechanisms to therapy. Molecular Therapy - Nucleic Acids. 2021;23:1136\u201360. https:\/\/doi.org\/10.1016\/j.omtn.2021.01.024.","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"1","key":"5358_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5(1):56. https:\/\/doi.org\/10.1038\/s41572-019-0106-z.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"5358_CR18","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1161\/STROKEAHA.116.012650","volume":"47","author":"E Zapata-Arriaza","year":"2016","unstructured":"Zapata-Arriaza E, Moniche F, Gonzalez A, et al. Predictors of restenosis following carotid angioplasty and stenting. Stroke. 2016;47(8):2144\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.116.012650.","journal-title":"Stroke"},{"issue":"12","key":"5358_CR19","doi-asserted-by":"publisher","first-page":"CD003075","DOI":"10.1002\/14651858.CD003075.pub3","volume":"2013","author":"DA Lane","year":"2013","unstructured":"Lane DA, Lip GY. Treatment of hypertension in peripheral arterial disease. Cochrane Database Syst Rev. 2013;2013(12):CD003075. https:\/\/doi.org\/10.1002\/14651858.CD003075.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"5358_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928.","journal-title":"BMJ"},{"issue":"4","key":"5358_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.amjcard.2011.10.005","volume":"109","author":"SY Choi","year":"2012","unstructured":"Choi SY, Maehara A, Cristea E, et al. Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy). Am J Cardiol. 2012;109(4):455\u201360. https:\/\/doi.org\/10.1016\/j.amjcard.2011.10.005.","journal-title":"Am J Cardiol"},{"issue":"2","key":"5358_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1479164111403784","volume":"8","author":"C Hage","year":"2011","unstructured":"Hage C, Grip L, Malmberg K, Ryden L, Wallander M, Saleh N. The predictive value of inflammatory activity and markers of the adipo-insular axis on restenosis in patients with type 2 diabetes. Diab Vasc Dis Res. 2011;8(2):143\u20139. https:\/\/doi.org\/10.1177\/1479164111403784.","journal-title":"Diab Vasc Dis Res"},{"issue":"6","key":"5358_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1590\/s1807-59322011000600011","volume":"66","author":"LM Abreu Filho","year":"2011","unstructured":"Abreu Filho LM, Forte AA, Sumita MK, Favarato D, Meireles GC. Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease. Clinics (Sao Paulo). 2011;66(6):985\u20139. https:\/\/doi.org\/10.1590\/s1807-59322011000600011.","journal-title":"Clinics (Sao Paulo)"},{"issue":"4","key":"5358_CR24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ahj.2009.07.025","volume":"158","author":"E Nikolsky","year":"2009","unstructured":"Nikolsky E, Lansky AJ, Sudhir K, et al. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease. Am Heart J. 2009;158(4):520\u2013e5262. https:\/\/doi.org\/10.1016\/j.ahj.2009.07.025.","journal-title":"Am Heart J"},{"issue":"16","key":"5358_CR25","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.jcin.2017.05.015","volume":"10","author":"H Krankenberg","year":"2017","unstructured":"Krankenberg H, Zeller T, Ingwersen M, et al. Self-Expanding versus Balloon-Expandable stents for Iliac artery occlusive disease: the randomized ICE trial. JACC Cardiovasc Interv. 2017;10(16):1694\u2013704. https:\/\/doi.org\/10.1016\/j.jcin.2017.05.015.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"5358_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22666","volume":"33","author":"Y Wu","year":"2019","unstructured":"Wu Y, Fu X. Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents implantation. J Clin Lab Anal. 2019;33(2):e22666. https:\/\/doi.org\/10.1002\/jcla.22666.","journal-title":"J Clin Lab Anal"},{"key":"5358_CR27","doi-asserted-by":"publisher","unstructured":"Robertson L, Ghouri MA, Kovacs F. Antiplatelet and anticoagulant drugs for prevention of restenosis\/reocclusion following peripheral endovascular treatment. Cochrane Database of Systematic Reviews. 2012;10.1002\/14651858.CD002071.pub3. https:\/\/doi.org\/10.1002\/14651858.CD002071.pub3.","DOI":"10.1002\/14651858.CD002071.pub3"},{"issue":"8","key":"5358_CR28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/circresaha.111.246876","volume":"110","author":"BJ North","year":"2012","unstructured":"North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110(8):1097\u2013108. https:\/\/doi.org\/10.1161\/circresaha.111.246876.","journal-title":"Circ Res"},{"issue":"12","key":"5358_CR29","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1001\/jamaneurol.2020.3362","volume":"77","author":"F Akbik","year":"2020","unstructured":"Akbik F, Xu H, Xian Y, et al. Trends in reperfusion therapy for in-hospital ischemic stroke in the endovascular therapy era. JAMA Neurol. 2020;77(12):1486\u201395. https:\/\/doi.org\/10.1001\/jamaneurol.2020.3362.","journal-title":"JAMA Neurol"},{"key":"5358_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells11132094","author":"T Gori","year":"2022","unstructured":"Gori T. Restenosis after coronary stent implantation: cellular mechanisms and potential of endothelial progenitor cells (a short guide for the interventional cardiologist). Cells. 2022. https:\/\/doi.org\/10.3390\/cells11132094.","journal-title":"Cells"},{"issue":"10","key":"5358_CR31","doi-asserted-by":"publisher","first-page":"E1150","DOI":"10.21037\/jtd.2016.10.93","volume":"8","author":"D Buccheri","year":"2016","unstructured":"Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8(10):E1150\u201362. https:\/\/doi.org\/10.21037\/jtd.2016.10.93.","journal-title":"J Thorac Dis"},{"key":"5358_CR32","doi-asserted-by":"publisher","unstructured":"Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315\u201323. https:\/\/doi.org\/10.1056\/NEJMoa035071.","DOI":"10.1056\/NEJMoa035071"},{"issue":"5","key":"5358_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00059-017-4574-1","volume":"42","author":"JA Wermelt","year":"2017","unstructured":"Wermelt JA, Schunkert H. [Management of arterial hypertension]. Herz. 2017;42(5):515\u201326. https:\/\/doi.org\/10.1007\/s00059-017-4574-1. Management der arteriellen Hypertonie.","journal-title":"Herz"},{"issue":"2","key":"5358_CR34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1161\/HYPERTENSIONAHA.114.03617","volume":"65","author":"Z Sun","year":"2015","unstructured":"Sun Z. Aging, arterial stiffness, and hypertension. Hypertension. 2015;65(2):252\u20136. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03617.","journal-title":"Hypertension"},{"issue":"2","key":"5358_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1152\/physiol.00026.2016","volume":"32","author":"BC Rossier","year":"2017","unstructured":"Rossier BC, Bochud M, Devuyst O. The hypertension pandemic: an evolutionary perspective. Physiol (Bethesda). 2017;32(2):112\u201325. https:\/\/doi.org\/10.1152\/physiol.00026.2016.","journal-title":"Physiol (Bethesda)"},{"issue":"1 Pt 2","key":"5358_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0002-8703(88)90108-1","volume":"116","author":"A Chobanian","year":"1988","unstructured":"Chobanian A. Overview: hypertension and atherosclerosis. Am Heart J. 1988;116(1 Pt 2):319\u201322. https:\/\/doi.org\/10.1016\/0002-8703(88)90108-1.","journal-title":"Am Heart J"},{"key":"5358_CR37","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/281240","volume":"2011","author":"C Savoia","year":"2011","unstructured":"Savoia C, Sada L, Zezza L, et al. Vascular inflammation and endothelial dysfunction in experimental hypertension. Int J Hypertens. 2011;2011:281240. https:\/\/doi.org\/10.4061\/2011\/281240.","journal-title":"Int J Hypertens"},{"issue":"4","key":"5358_CR38","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/fjc.0b013e3181d7671c","volume":"55","author":"WT Wong","year":"2010","unstructured":"Wong WT, Wong SL, Tian XY, Huang Y. Endothelial dysfunction: the common consequence in diabetes and hypertension. J Cardiovasc Pharmacol. 2010;55(4):300\u20137. https:\/\/doi.org\/10.1097\/fjc.0b013e3181d7671c.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"5358_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s12265-012-9349-8","volume":"5","author":"JE Wagenseil","year":"2012","unstructured":"Wagenseil JE, Mecham RP. Elastin in large artery stiffness and hypertension. J Cardiovasc Transl Res. 2012;5(3):264\u201373. https:\/\/doi.org\/10.1007\/s12265-012-9349-8.","journal-title":"J Cardiovasc Transl Res"},{"issue":"3","key":"5358_CR40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/cvr\/cvw061","volume":"110","author":"L Duca","year":"2016","unstructured":"Duca L, Blaise S, Romier B, et al. Matrix ageing and vascular impacts: focus on elastin fragmentation. Cardiovasc Res. 2016;110(3):298\u2013308. https:\/\/doi.org\/10.1093\/cvr\/cvw061.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"5358_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1046\/j.1440-1681.2002.03622.x","volume":"29","author":"BA Kingwell","year":"2002","unstructured":"Kingwell BA. Large artery stiffness: implications for exercise capacity and cardiovascular risk. Clin Exp Pharmacol Physiol. 2002;29(3):214\u20137. https:\/\/doi.org\/10.1046\/j.1440-1681.2002.03622.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"5358_CR42","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.116.303596","volume":"116","author":"S Laurent","year":"2015","unstructured":"Laurent S, Boutouyrie P. The structural factor of hypertension: large and small artery alterations. Circ Res. 2015;116(6):1007\u201321. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303596.","journal-title":"Circ Res"},{"issue":"1","key":"5358_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1742-7843.2011.00758.x","volume":"110","author":"MJ Mulvany","year":"2012","unstructured":"Mulvany MJ. Small artery remodelling in hypertension. Basic Clin Pharmacol Toxicol. 2012;110(1):49\u201355. https:\/\/doi.org\/10.1111\/j.1742-7843.2011.00758.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"5358_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/01.res.61.2.181","volume":"61","author":"C Aalkjaer","year":"1987","unstructured":"Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation\u2013contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res. 1987;61(2):181\u20136. https:\/\/doi.org\/10.1161\/01.res.61.2.181.","journal-title":"Circ Res"},{"issue":"5","key":"5358_CR45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nrcardio.2017.12","volume":"14","author":"Y Miyazaki","year":"2017","unstructured":"Miyazaki Y, Suwannasom P, Sotomi Y, et al. Single or dual antiplatelet therapy after PCI. Nat Rev Cardiol. 2017;14(5):294\u2013303. https:\/\/doi.org\/10.1038\/nrcardio.2017.12.","journal-title":"Nat Rev Cardiol"},{"key":"5358_CR46","doi-asserted-by":"publisher","first-page":"762391","DOI":"10.3389\/fcvm.2021.762391","volume":"8","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang X, Dong Q, Chen D, Xu Y, Jiang J. Duration of dual antiplatelet therapy after implantation of drug-coated balloon. Front Cardiovasc Med. 2021;8:762391. https:\/\/doi.org\/10.3389\/fcvm.2021.762391.","journal-title":"Front Cardiovasc Med"},{"key":"5358_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.phrs.2014.12.003","volume":"93","author":"A Habib","year":"2015","unstructured":"Habib A, Finn AV. Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration. Pharmacol Res. 2015;93:22\u20137. https:\/\/doi.org\/10.1016\/j.phrs.2014.12.003.","journal-title":"Pharmacol Res"},{"issue":"7","key":"5358_CR48","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jacc.2015.05.053","volume":"66","author":"G Montalescot","year":"2015","unstructured":"Montalescot G, Brieger D, Dalby AJ, Park SJ, Mehran R. Duration of dual antiplatelet therapy after coronary stenting: a review of the evidence. J Am Coll Cardiol. 2015;66(7):832\u201347. https:\/\/doi.org\/10.1016\/j.jacc.2015.05.053.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"5358_CR49","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","volume":"371","author":"L Mauri","year":"2014","unstructured":"Mauri L, Kereiakes DJ, Yeh RW, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014;371(23):2155\u201366. https:\/\/doi.org\/10.1056\/NEJMoa1409312.","journal-title":"N Engl J Med"},{"issue":"1","key":"5358_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.114.013570","volume":"131","author":"KN Garratt","year":"2015","unstructured":"Garratt KN, Weaver WD, Jenkins RG, et al. Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberte paclitaxel-eluting coronary stent placement. Circulation. 2015;131(1):62\u201373. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013570.","journal-title":"Circulation"},{"issue":"9954","key":"5358_CR51","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(14)60612-7","volume":"384","author":"JP Collet","year":"2014","unstructured":"Collet JP, Silvain J, Barthelemy O, et al. Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial. Lancet. 2014;384(9954):1577\u201385. https:\/\/doi.org\/10.1016\/S0140-6736(14)60612-7.","journal-title":"Lancet"},{"issue":"23","key":"5358_CR52","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1001\/jama.2013.282183","volume":"310","author":"F Feres","year":"2013","unstructured":"Feres F, Costa RA, Abizaid A, et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA. 2013;310(23):2510\u201322. https:\/\/doi.org\/10.1001\/jama.2013.282183.","journal-title":"JAMA"},{"issue":"1","key":"5358_CR53","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/cvr\/cvt082","volume":"99","author":"P Li","year":"2013","unstructured":"Li P, Liu Y, Yi B, et al. MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1. Cardiovasc Res. 2013;99(1):185\u201393. https:\/\/doi.org\/10.1093\/cvr\/cvt082.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"5358_CR54","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/0002-9149(93)90510-j","volume":"71","author":"JJ Popma","year":"1993","unstructured":"Popma JJ, De Cesare NB, Pinkerton CA, et al. Quantitative analysis of factors influencing late lumen loss and restenosis after directional coronary atherectomy. Am J Cardiol. 1993;71(7):552\u20137. https:\/\/doi.org\/10.1016\/0002-9149(93)90510-j.","journal-title":"Am J Cardiol"},{"key":"5358_CR55","doi-asserted-by":"publisher","unstructured":"Holmes DR Jr., Vlietstra RE, Smith HC et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol. 1984;53(12):77\u00a0C-81C. https:\/\/doi.org\/10.1016\/0002-9149(84)90752-5.","DOI":"10.1016\/0002-9149(84)90752-5"},{"issue":"6","key":"5358_CR56","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/ccd.22624","volume":"76","author":"RA Brown","year":"2010","unstructured":"Brown RA, Williams M, Barker CM, et al. Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late-term clinical results. Catheter Cardiovasc Interv. 2010;76(6):804\u201313. https:\/\/doi.org\/10.1002\/ccd.22624.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"22","key":"5358_CR57","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1161\/01.CIR.0000131898.18849.65","volume":"109","author":"M Singh","year":"2004","unstructured":"Singh M, Gersh BJ, McClelland RL, et al. Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the prevention of restenosis with Tranilast and its outcomes (PRESTO) trial. Circulation. 2004;109(22):2727\u201331. https:\/\/doi.org\/10.1161\/01.CIR.0000131898.18849.65.","journal-title":"Circulation"},{"issue":"3","key":"5358_CR58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/heart.84.3.233","volume":"84","author":"JP Pell","year":"2000","unstructured":"Pell JP. Does smoking cessation reduce the risk of restenosis following coronary angioplasty? Heart. 2000;84(3):233\u20134. https:\/\/doi.org\/10.1136\/heart.84.3.233.","journal-title":"Heart"},{"issue":"11","key":"5358_CR59","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1056\/NEJM199703133361103","volume":"336","author":"D Hasdai","year":"1997","unstructured":"Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR Jr. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med. 1997;336(11):755\u201361. https:\/\/doi.org\/10.1056\/NEJM199703133361103.","journal-title":"N Engl J Med"},{"issue":"7","key":"5358_CR60","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/hc3201.094225","volume":"104","author":"DJ Cohen","year":"2001","unstructured":"Cohen DJ, Doucet M, Cutlip DE, Ho KK, Popma JJ, Kuntz RE. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker\u2019s paradox? Circulation. 2001;104(7):773\u20138. https:\/\/doi.org\/10.1161\/hc3201.094225.","journal-title":"Circulation"},{"issue":"1","key":"5358_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nrcardio.2011.132","volume":"9","author":"JW Jukema","year":"2011","unstructured":"Jukema JW, Verschuren JJ, Ahmed TA, Quax PH. Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol. 2011;9(1):53\u201362. https:\/\/doi.org\/10.1038\/nrcardio.2011.132.","journal-title":"Nat Rev Cardiol"},{"issue":"38","key":"5358_CR62","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3238\/arztebl.m2021.0254","volume":"118","author":"H Ullrich","year":"2021","unstructured":"Ullrich H, Olschewski M, Munzel T, Gori T. Coronary in-stent restenosis: predictors and treatment. Dtsch Arztebl Int. 2021;118(38):637\u201344. https:\/\/doi.org\/10.3238\/arztebl.m2021.0254.","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"5358_CR63","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/s0735-1097(98)00286-1","volume":"32","author":"A Abizaid","year":"1998","unstructured":"Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol. 1998;32(3):584\u20139. https:\/\/doi.org\/10.1016\/s0735-1097(98)00286-1.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5358_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12933-024-02201-6","volume":"23","author":"X Sun","year":"2024","unstructured":"Sun X, Zhang C, Ma Y, He Y, Zhang X, Wu J. Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials. Cardiovasc Diabetol. 2024;23(1):10\u20131186. s12933-024-02201-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"5358_CR65","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/path.1598","volume":"203","author":"MS Lee","year":"2004","unstructured":"Lee MS, David EM, Makkar RR, Wilentz JR. Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system. J Pathol. 2004;203(4):861\u201370. https:\/\/doi.org\/10.1002\/path.1598.","journal-title":"J Pathol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05358-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05358-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05358-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:12:29Z","timestamp":1767028349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-025-05358-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5358"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05358-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. As this study is a meta-analysis based exclusively on previously published scientific literature, no direct patient data or individual participant information was collected for this research. Therefore, obtaining patient consent for publication was not required by our institutional ethics committee and is in accordance with the ICMJE recommendations regarding the use of published data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"878"}}